ClinicalTrials.gg
CompletedNCT07317518Updated Nov 3, 2026

The Effect of Different Kinesio Taping Techniques Applied to Patients With Chronic Low Back Pain on the Thoracolumbar Fascia

An interventional study of Functional Fascial Taping Group and Muscle Technique Taping Group in Low Back Pain, sponsored by Kirsehir Ahi Evran Universitesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Kirsehir Ahi Evran Universitesi · Not applicable, Interventional, and Treatment

How we know

Updated Nov 3, 2026Now CompletedStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi — 5 open to participants now, 5 under way, none of them phase 3. Low Back Pain · Kirsehir Ahi Evran Universitesi.

Started
2026
with 3 others
No phase
9 of 13
3 open now
Registered
10th of 13
by date

Among the 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi, this one is one of 4 that started in 2026, is one of 9 with no phase, and was the 10th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

5 of the 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi, or all of them as a file.
02

Study summary

This study aims to evaluate the effects of functional thoracolumbar fascia kinesiology taping on fascia thickness, pain, and functional disability in individuals with nonspecific chronic low back pain. The study is planned as a randomized controlled trial and will include a total of 30 individuals aged 18-65 years who have been diagnosed with nonspecific mechanical chronic low back pain. Participants will be randomly assigned to two groups: the Functional Fascial Taping Group will receive kinesiology tape applied to the thoracolumbar fascia using a fascia correction technique, while the Muscle Technique Taping Group will receive traditional muscle taping applied to the paravertebral muscles. Interventions will be performed twice a week for two weeks. Assessments will be performed before and after treatment; pain intensity will be measured using the Visual Analog Scale, pressure pain threshold will be measured using an algometer, functional disability will be measured using the Oswestry Low Back Pain Disability Index, and thoracolumbar fascia thickness will be measured using ultrasonography. The findings are expected to contribute to clinical practice by providing evidence-based data on the effectiveness of different kinesiology taping techniques in chronic low back pain.

Read the detailed description

Non-specific chronic low back pain is a highly prevalent musculoskeletal condition associated with recurrent symptoms, functional limitations, and substantial psychosocial burden. Current clinical practice frequently relies on passive treatment approaches, including various taping techniques; however, the specific effects of different kinesio taping methods on fascial structures remain insufficiently explored. In particular, objective evidence regarding changes in thoracolumbar fascia morphology following targeted taping interventions is limited.

This randomized controlled study aims to compare the effects of functional fascial kinesio taping and conventional muscle taping on thoracolumbar fascia thickness, pain perception, and functional disability in individuals with non-specific chronic low back pain. Participants diagnosed with non-specific mechanical chronic low back pain will be randomly allocated to one of two intervention groups. One group will receive functional fascial taping applied according to movement-based pain modulation principles, while the comparison group will receive traditional muscle-oriented kinesio taping. Both interventions will be administered over a short-term treatment period without additional therapeutic modalities to isolate the effects of taping.

Outcome assessment will focus on changes in pain intensity, pressure pain sensitivity, functional disability, and thoracolumbar fascial characteristics. Fascial thickness will be evaluated using ultrasonographic imaging to provide an objective measure of tissue-level response. By integrating subjective clinical outcomes with imaging-based assessment, this study seeks to clarify whether taping strategies that target fascial mechanics offer advantages over conventional muscle-focused approaches.

The findings are expected to contribute to evidence-based decision-making in rehabilitation practice by informing clinicians about the potential role of fascia-oriented taping in the management of chronic low back pain, while minimizing redundancy with procedural and technical details documented elsewhere in the study record.

03

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • Non-specific chronic low back pain
  • Kinesio taping
  • Thoracolumbar fascia
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: Be between 18 and 65 years old.
  • Volunteer status: Be willing to participate in the study and sign an form.
  • Diagnosis: Have been diagnosed by a physician with nonspecific mechanical chronic low back pain. This diagnosis is defined as follows:
  • A pain episode lasting longer than 6 weeks or
  • A history of recurrent low back pain (episodes lasting longer than 24 hours with at least one pain-free period of one month before/after the episode).
  • Localization: Pain localized between the lowest rib and the gluteal folds.

Exclusion criteria

Exclusion Criteria:

  • Specific Spinal Pathologies: The presence of a specific cause for back pain (e.g., structural abnormalities such as herniation, stenosis, spondylolisthesis).
  • History of Major Trauma: A history of serious trauma to the back region.
  • Systemic Diseases: Systemic diseases that may affect the outcome, such as rheumatological diseases or diabetes.
  • History of Cancer: Any cancer diagnosis or history.
  • Osteoporosis: Diagnosis of bone loss.
  • Inflammatory or Neurological Diseases: Diagnosis of inflammatory rheumatic diseases such as ankylosing spondylitis or a neurological disease.
  • Radicular Pain: Presence of radicular pain radiating to the legs, suggesting nerve root compression.

Skin Conditions:

  • Known skin sensitivity or allergy to the patches.
  • Active dermatitis or pre-existing skin lesion in the patch application area.
  • Recent Treatments: Having undergone a physical therapy and rehabilitation (PTR) program targeting the lumbar region or an intervention such as an injection within the last 3 months prior to the start of the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
66 participants (actual)

Study arms

  • Experimental
    Group 1 (Functional Fascial Taping Group):

    For this group, "I" and "Y" kinesiology tape will be applied using a fascial correction technique on the thoracolumbar fascia with 10-50% oscillatory (oscillating) tension. The taping direction will be determined based on the direction in which pain is most reduced during movement.

    Other: Functional Fascial Taping Group · Other: Traditional treatment

  • Active comparator
    Group 2 (Muscle Technique Taping Group):

    This group will be applied using "I" strip kinesiology tape muscle taping techniques on the paravertebral muscles. Two of the tapes will be applied completely tension-free (0%), while one will be applied transversely to the sacroiliac region with 25% tension.

    Other: Muscle Technique Taping Group · Other: Traditional treatment

  • Sham comparator
    Group 3 (Damascus Taping Group):

    This group will receive kinesiology tape applied symbolically to the skin over the thoracolumbar region without any therapeutic taping technique, without targeting fascia or muscle correction, and without creating meaningful tension (0% tension). Sham taping will be used to control for the placebo effect, independent of the specific mechanical and neurophysiological effects of taping.

    Other: Damascus Banding Group · Other: Traditional treatment

Interventions

  • OtherFunctional Fascial Taping Group

    The treatment program for the Functional Fascial Taping Group is as follows: Participants in this group will undergo a targeted fascial correction technique applied to the thoracolumbar fascia. In practice, "I" and "Y" strips cut from 5 cm x 5 m kinesiology tape will be used, and the tapes will be applied to the right and left thoracolumbar fascia with an oscillatory (oscillating) tension in the range of 10-50%. The protocol will be repeated for a total of 2 weeks (4 sessions), twice a week, and the tapes will be replaced at each session. The primary goal is to reduce pain and improve function by directly affecting the biomechanics of the fascial tissue. Patients in the stabilization exercises group will perform cervical stabilization exercises consisting of 3 levels with gradually increasing difficulty. The exercises will be taught to patients level by level by a physical therapist over 6 weeks. Stretching exercises will be performed before each exercise session.

  • OtherMuscle Technique Taping Group

    In this group, the more traditional approach of muscle taping will be adopted. The application will be performed using three "I"-shaped strips of tape. The first two strips will be placed completely tension-free (0%) on the paravertebral muscles while the patient is leaning forward and performing a slight rotation. The third tape will be applied transversally with 25% tension, parallel to the ground, over the sacroiliac joints. This protocol will also be applied twice a week for two weeks, with the aim of providing muscle support and increasing stabilization.

  • OtherDamascus Banding Group

    The taping applied in this group will not aim to correct any muscles or fascia, will be performed without applying therapeutic tension (0% tension), and will not produce a standard clinical effect. At the end of the study, all participants will be informed that they can access known effective taping approaches upon request.

  • OtherTraditional treatment

    Patients in the stabilization exercise group will be given cervical stabilization exercises consisting of 3 levels with gradually increasing difficulty. The exercises will be taught to patients level by level by a physical therapist over 6 weeks. Patients will perform the exercises for a total of 6 weeks. Patients will be asked to perform stretching exercises before each exercise session.

06

What researchers measure

Primary outcomes

  1. Pain intensity

    The Visual Analog Scale (VAS) will be used to measure participants' pain intensity. Participants are asked to indicate their current state by placing a line or dot on a 10-centimeter straight line, where both ends are defined by the parameter to be measured in the individual. Pain intensity in the individual is calculated in this way. For example, the parameters to be evaluated are determined at one end of the drawn 10-centimeter straight line (0 = no pain, 10 = unbearable pain).

    Time frame: 6 week

  2. The thoracolumbar fascia thickness/ULTRASOUND

    The thoracolumbar fascia thickness will be measured using the Versana Primer R2 VS GE (China, 2022) ultrasound with a 4.0-13.0 MHz, 38.4 mm probe and a scanning protocol performed at the L3 level of the lumbar spine. Measurements will be performed by an experienced physician doctor in musculoskeletal ultrasound. Measurements will be performed bilaterally in the standard manner, with the patient lying comfortably in the prone position. Measurements will be performed using ultrasound B-mode and a depth setting of 30 mm. Sufficient gel will be used to avoid probe compression on the skin to ensure accurate measurements. To prevent TLF thickness differences from affecting the results, measurements will be taken at 3 separate points and averaged. As recommended by Pirri et al., the probe will be placed perpendicularly, and short and long axis images will be obtained. Images will be recorded and measurements will be taken (Pirri et al., 2024).

    Time frame: 6 week

Secondary outcomes

  1. LOW BACK PAIN DISABILITY

    The Oswestry Back Pain Disability Questionnaire will be used to obtain information about how much back (or leg) pain affects a person's daily activities. The questionnaire consists of 10 sections. The patient is asked to mark the most appropriate answer for themselves. The score is calculated, and the resulting percentage values are interpreted according to the values given below (Yi, 2008); 0% - 20% - minimal disability 20% - 40% - moderate disability 40% - 60% - severe disability 60% - 80% - disabled 80% - 100% - bedridden

    Time frame: 6 week

  2. Posture

    Spinal posture was assessed using a computer-assisted wireless Spinal Mouse device (Spinal Mouse System, Idiag, Fehraltorf, Switzerland). The device was guided manually along the spinous processes from C7 to S3 while the participant stood in a relaxed upright position. The Spinal Mouse records sagittal spinal curvature and calculates numerical values for thoracic kyphosis, lumbar lordosis, and overall spinal inclination. All postural alignment parameters were automatically transferred to the computer software and expressed as angular values (degrees).

    Time frame: 6 week

  3. Lateral Bridge Testt

    The lateral bridge test will be used to evaluate lateral core muscle endurance. Participants will be instructed to lie on their right side, supporting their body on the forearm and feet, with the body aligned in a straight line. The non-supporting arm will rest along the body. Participants will be asked to maintain this position for as long as possible. The test will be terminated when proper alignment is lost or when the pelvis contacts the examination surface. The duration the position is held will be recorded in seconds (Bliss \& Teeple, 2005).

    Time frame: 6 week

  4. Spinal Mobility:

    Spinal mobility was evaluated with the same Spinal Mouse system by assessing trunk flexion posture. Participants were instructed to perform maximal trunk flexion from the standing position, and the device was rolled along the spine during the movement. The Spinal Mouse quantitatively measured segmental and total spinal range of motion by calculating angular changes between adjacent vertebral segments. The system provides cumulative numerical values for spinal flexion mobility in degrees. Spinal mobility measurements were recorded at baseline and at the 6-week follow-up.

    Time frame: 6 week

  5. Postural Endurance (Postural Competence):

    Postural endurance was assessed using the Spinal Mouse device during a standardized static loading task. Participants were asked to hold a weight equivalent to 5% of their body weight with both hands at shoulder level, arms parallel to the floor, for 30 seconds while maintaining an upright posture. Immediately after the task, spinal posture was re-measured using the Spinal Mouse. Changes in spinal alignment angles before and after the endurance task were calculated numerically by the software and used as indicators of postural endurance (competence).

    Time frame: 6 week

  6. Static Trunk Extension Test (Sorensen Test):

    The Sorensen test will be performed to assess endurance of the trunk extensor muscles. Participants will lie in a prone position with the pelvis, hips, and knees supported on the examination table, while the upper body extends beyond the edge of the table. The lower extremities will be stabilized by straps or manual fixation. Participants will be instructed to maintain the upper body in a horizontal position with arms crossed over the chest. The test will end when the participant is unable to maintain the horizontal position or reports fatigue. Endurance time will be recorded in seconds (Baltacı et al., 2006).

    Time frame: 6 week

  7. Trunk Flexor Endurance Test

    Trunk flexor endurance will be assessed using a standardized static trunk flexion test. Participants will sit on the examination table with the trunk flexed to approximately 60 degrees, hips and knees flexed, and feet secured. Arms will be crossed over the chest. Participants will be instructed to maintain this position without support for as long as possible. The test will be terminated when the participant is unable to maintain the target position or reports exhaustion. The duration will be measured in seconds using a stopwatch (Bliss \& Teeple, 2005).

    Time frame: 6 week

07

Study locations

1 site
  • Kirşehir Ahi Evran Univercity
    Center, Kirşehi̇r, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2026 to primary completion in Jun 2026, 3 months.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's 3 months is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: start Jan 2026 → Feb 2026, primary completion May 2026 → Jun 2026 and completion May 2026 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 15, 2025
First posted
Jan 5, 2026
StartActual
Feb 19, 2026was Jan 2026
Primary completionActual
Jun 1, 2026was May 2026
CompletionActual
Jul 15, 2026was May 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 3, 2026
Start date
Jan 19, 2026→Feb 19, 2026
Nov 3, 2026
Primary completion
May 1, 2026→Jun 1, 2026 (actual)
Nov 3, 2026
Study completion
May 15, 2026→Jul 15, 2026 (actual)
Nov 3, 2026
Enrollment
60 (estimated)→66 (actual)
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Recruiting→Completed
    Start date Jan 19, 2026→Feb 19, 2026
    Primary completion May 1, 2026→Jun 1, 2026 (now actual)
    Study completion May 15, 2026→Jul 15, 2026 (now actual)
    Enrollment 60 (estimated)→66 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07317518
Responsible party
Safak Kuzu (Assist. Prof., Kirsehir Ahi Evran Universitesi) — Principal investigator
First posted
Jan 5, 2026
Start date
Feb 19, 2026
Primary completion
Jun 1, 2026
Completion
Jul 15, 2026
Last update
Nov 3, 2026

Study contacts

Şafak KUZU
study director · Kirsehir Ahi Evran Universitesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion